• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number PAJ061002
Device Problems Difficult to Insert (1316); Insufficient Information (3190)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/11/2017
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing records for the device verified the lot met all pre-release specifications.The device was received for analysis and the investigation is in process.Further information will be provided.(b)(4).
 
Event Description
On (b)(6) 2017, a patient was being treated for a superficial femoral artery (sfa) occlusion using a gore® viabahn® endoprosthesis with heparin bioactive surface.The patient had a history of a popliteal aneurysm.Reportedly, the patient had a thrombosed popliteal artery and the anterior tibial artery required a thrombectomy procedure.10mg of thrombolytics (tpa) was delivered via power pulse followed 10-15 minutes later with mechanical thrombectomy (angiojet) with good result.Then, a 6mm x 10cm device was intended to be used in the popliteal artery.At some point during the implant process, the deployment line was pulled, however the device only partially deployed 2cm, and could not be removed from the patient through the 6fr flexor sheath.The physician attempted to remove the sheath and the stent delivery mechanism together, however, the partially deployed stent prevented this.The physician cut the stent delivery system in order to advance a larger 10fr sheath over the delivery system in an attempt to remove the stent which was successful.Reportedly, the physician successfully deployed another gore® viabahn® endoprosthesis with heparin bioactive surface (paj061502/ 16391537) into the sfa and closed with a proglide.The patient did have a pseudoaneurysm the following day which required thrombin injection.The patient tolerated the procedure.
 
Manufacturer Narrative
The device was sent to gore for the engineering analysis and it was observed that a deployment knob with a section of the deployment line still attached.The deployment line segment measured approximately 40.5cm.The deployment line appeared to be cut.A separate segment of deployment line remained attached at the endoprosthesis.The catheter was returned in 2 pieces.One piece consisted of the deployment hub connected to a section of proximal catheter tubing that measured approximately 5.5cm.The tubing appeared cut.The second piece measured approximately 119.5cm from the cut end of the catheter tubing to the end of the distal tip.The endoprosthesis was still mounted on the distal shaft.The endoprosthesis was longitudinally compressed towards the transition.Approximately 1.2cm of the distal shaft, upon which the endoprosthesis was mounted, was exposed at the distal tip.Approximately 2.5cm of the endoprosthesis on the distal tip end was expanded.The transition end of the endoprosthesis was constrained by the inner braided constraining line, which was compressed.At 1.3cm and 2.0cm from the tip end, the endoprosthesis was radially constricted.Some strut rows in the partially deployed section of the endoprosthesis were detached from the graft.A segment of deployment line measuring 104.5cm was attached to the inner braided constraining line by a single fiber.Where the fiber joined the full deployment line, the deployment line appeared to be unraveled with fiber breaks.The opposite end of the deployment line appeared cut.The single fiber measured approximately 26.5cm.Further deployment was not able to be continued with traction on the single fiber at the endoprosthesis.Based on the device examination performed, no manufacturing anomalies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7105446
MDR Text Key94944205
Report Number2017233-2017-00639
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/22/2019
Device Catalogue NumberPAJ061002
Device Lot Number15980134
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/06/2017
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/22/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
-
-